NICE calls for wider use of statins

doi:10.1136/bmj.332.7536.256-d

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ research articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Susan Mayor

London

Treatment with statins should be considered in patients with clinical evidence of cardiovascular disease and in people with a 20% or greater risk of developing the disease within 10 years. This was the recommended guidance to the NHS in England and Wales published last week, which will make an additional 3.3 million people eligible for these drugs.

The National Institute for Health and Clinical Excellence (NICE), the body that advises on the use of treatments by the NHS, reviewed all available studies on the efficacy and cost …